ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 34.9 | 34.6 | 31.8 |
| Other income | 0.2 | 0.2 | 0.2 |
| Total income | 35.1 | 34.8 | 32.0 |
| Profit before exceptional items & tax | 0.5 | -0.9 | 2.7 |
| Profit before tax | 0.5 | -0.9 | 2.7 |
| Net profit | 0.7 | -0.9 | 2.0 |
| Operating margin | 1.4% | -2.6% | 8.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -65.00% |
|---|---|
| Revenue, year on year | +9.70% |
NSE results filing, NSE: ONYX. Figures extracted from the filing.
Onyx Biotec Ltd: key numbers
- Share price
- ₹37.45
- Market cap
- ₹67.91 Cr
- Revenue (annual)
- ₹69.47 Cr
- Net profit (annual)
- ₹-0.21 Cr
- P/E (TTM)
- -316.7×Sector 43.8×
- Promoter holding
- 41.74%
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Onyx Biotec Ltd
All →Onyx Biotec Open Offer
VC Corporate Advisors filed a corrigendum to Onyx Biotec's open offer letter of offer. The offer seeks up to 47,14,372 shares, or 26% of paid-up capital.
Onyx Biotec Other Announcement
Onyx Biotec Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Onyx Biotec Open Offer
Onyx Biotec's Committee of Independent Directors met to review the open offer by the identified acquirers to purchase 26% of the company's equity share capital.
Onyx Biotec Open Offer: ₹17.21 Cr
Bhardwaj acquirers launch a ₹172.07 Crore open offer for 26% of Onyx Biotec at ₹36.5 per share. Tendering runs October 13–27, 2026.
- Value
- ₹17.21 Cr
Onyx Biotec Annual General Meeting
Onyx Biotec Limited held its 21st Annual General Meeting on September 28, 2026. The meeting covered standard agenda items including financial statement adoption and director appointments.
Onyx Biotec Annual General Meeting
Onyx Biotec Limited will hold its 21st Annual General Meeting on September 28, 2026, via video conferencing to transact the company's business.